Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Change in Acquisitions & Divestments (2023)

Historic Change in Acquisitions & Divestments for OptimizeRx (OPRX) over the last 1 years, with Q4 2023 value amounting to $53.6 million.

  • OptimizeRx's Change in Acquisitions & Divestments changed N/A to $53.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $218.7 million, marking a year-over-year change of. This contributed to the annual value of $218.7 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q4 2023, OptimizeRx's Change in Acquisitions & Divestments is $53.6 million.
  • In the past 5 years, OptimizeRx's Change in Acquisitions & Divestments ranged from a high of $56.9 million in Q2 2023 and a low of $52.6 million during Q3 2023